Works matching DE "IPSEN Biopharm Ltd."

FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products.

Published in:

JAMA: Journal of the American Medical Association, 2009, v. 301, n. 22, p. 2316, doi. 10.1001/jama.2009.780

By:

• Kuehn, Bridget M.

Publication type:

Article